文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

少数HIV-1毒株在传播性耐药突变动态及疾病进展中的意义

Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

该研究对巴西25例近期HIV-1感染者基线和感染确立后1年的样本进行超深度测序,检测传播性耐药突变并与疾病进展相关。9例检出传播性耐药突变,频率低至1.6%;频率<14.8%的突变在感染确立后未持续存在。传播性耐药突变与病毒载量及CD4+ T细胞计数下降呈负相关。

要点

  • 超深度测序可检出频率低至1.6%的传播性耐药突变,群体血浆测序仅检出频率>20%的突变。
  • 频率<14.8%的传播性耐药突变在感染确立后未持续存在,提示被负向选择。
  • 传播性耐药突变的存在与病毒载量及CD4+ T细胞计数下降呈负相关。

核心结论

  • 传播性耐药突变中占病毒群体较小比例的突变在HIV-1血清阳转后第一年内因被负向选择而不持续存在。

研究设计与样本

  • 研究纳入巴西25例近期HIV-1感染者,采集近期感染基线及感染确立后1年的样本,对HIV-1逆转录酶和蛋白酶区域进行超深度测序,分析病毒RNA和原病毒DNA。

主要发现

  • 25例患者中9例检出携带传播性耐药突变的病毒株,覆盖所有主要抗逆转录病毒类别,每例患者携带1至5个突变。
  • 超深度测序检出频率低至1.6%的病毒株,而群体血浆测序仅检出3例患者中频率>20%的病毒株。
  • 频率<14.8%的传播性耐药株在感染确立后未持续存在。
  • 传播性耐药突变的存在与病毒载量及CD4+ T细胞计数下降呈负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The presence of minority transmitted drug resistance mutations was assessed using ultra-deep sequencing and correlated with disease progression among recently HIV-1-infected individuals from Brazil. METHODS: Samples at baseline during recent infection and 1 year after the establishment of the infection were analysed. Viral RNA and proviral DNA from 25 individuals were subjected to ultra-deep sequencing of the reverse transcriptase and protease regions of HIV-1. RESULTS: Viral strains carrying transmitted drug resistance mutations were detected in 9 out of the 25 patients, for all major antiretroviral classes, ranging from one to five mutations per patient. Ultra-deep sequencing detected strains with frequencies as low as 1.6% and only strains with frequencies >20% were detected by population plasma sequencing (three patients). Transmitted drug resistance strains with frequencies <14.8% did not persist upon established infection. The presence of transmitted drug resistance mutations was negatively correlated with the viral load and with CD4+ T cell count decay. CONCLUSIONS: Transmitted drug resistance mutations representing small percentages of the viral population do not persist during infection because they are negatively selected in the first year after HIV-1 seroconversion.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Leda AR, Hunter J, Oliveira UC, et al. Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression. J Antimicrob Chemother. 2018. PMID: 29684141. doi:10.1093/jac/dky132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。